The expression of CD44 and CD133 decreased (Supplementary Information, Figure S2E) and, to our surprise, human-specific endothelial-associated marker CD34 increased (Supplementary Information, Figure S2F) in the tumor nodules. The gene discussed is PROM1; the disease is neoplasm.